ATE270295T1 - Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit - Google Patents

Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit

Info

Publication number: ATE270295T1
Authority: AT; Austria
Prior art keywords: parkinson; disease; benzoxazine; treatment; alkyl
Prior art date: 2000-05-09

Application number

AT01925065T

Other languages

English (en)

Inventor

Corrine Elizab Augelli-Szafran

Thomas Boehme

Roy Douville Schwarz

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-09

Filing date

2001-04-17

Publication date

2004-07-15

2001-04-17 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2004-07-15 Application granted granted Critical

2004-07-15 Publication of ATE270295T1 publication Critical patent/ATE270295T1/de

Links

208000018737 Parkinson disease Diseases 0.000 title abstract 2
CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 title 1
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
208000016285 Movement disease Diseases 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
150000005130 benzoxazines Chemical class 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AT01925065T 2000-05-09 2001-04-17 Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit ATE270295T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US20278700P	2000-05-09	2000-05-09
PCT/US2001/012528 WO2001085734A1 (en)	2000-05-09	2001-04-17	Benzoxazines for use in the treatment of parkinson's disease

Publications (1)

Publication Number	Publication Date
ATE270295T1 true ATE270295T1 (de)	2004-07-15

Family

ID=22751255

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01925065T ATE270295T1 (de)	2000-05-09	2001-04-17	Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit

Country Status (13)

Country	Link
US (1)	US6812228B2 (de)
EP (1)	EP1282625B1 (de)
JP (1)	JP2003532733A (de)
AT (1)	ATE270295T1 (de)
AU (1)	AU2001251662A1 (de)
BR (1)	BR0110643A (de)
CA (1)	CA2407789A1 (de)
DE (1)	DE60104110T2 (de)
DK (1)	DK1282625T3 (de)
ES (1)	ES2223824T3 (de)
MX (1)	MXPA02010270A (de)
PT (1)	PT1282625E (de)
WO (1)	WO2001085734A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6087916B2 (ja)	2011-07-05	2017-03-01	エレクトロサイエンティフィックインダストリーズインコーポレーテッド	使用中の音響光学ビーム偏向器および音響光学変調器の温度安定性を実現するためのシステムならびに方法
US9463186B2 (en)	2013-04-15	2016-10-11	Northwestern University	Treatment for dopaminergic disorders
MX2021011588A (es) *	2019-03-25	2021-12-15	Cold Spring Harbor Laboratory	Antagonistas del receptor muscarinico de acetilcolina subtipo 4 en el tratamiento de la anemia.

2001
- 2001-04-17 AU AU2001251662A patent/AU2001251662A1/en not_active Abandoned
- 2001-04-17 ES ES01925065T patent/ES2223824T3/es not_active Expired - Lifetime
- 2001-04-17 US US10/275,825 patent/US6812228B2/en not_active Expired - Fee Related
- 2001-04-17 CA CA002407789A patent/CA2407789A1/en not_active Abandoned
- 2001-04-17 MX MXPA02010270A patent/MXPA02010270A/es not_active Application Discontinuation
- 2001-04-17 JP JP2001582334A patent/JP2003532733A/ja active Pending
- 2001-04-17 AT AT01925065T patent/ATE270295T1/de not_active IP Right Cessation
- 2001-04-17 EP EP01925065A patent/EP1282625B1/de not_active Expired - Lifetime
- 2001-04-17 WO PCT/US2001/012528 patent/WO2001085734A1/en not_active Ceased
- 2001-04-17 PT PT01925065T patent/PT1282625E/pt unknown
- 2001-04-17 DE DE60104110T patent/DE60104110T2/de not_active Expired - Fee Related
- 2001-04-17 BR BR0110643-0A patent/BR0110643A/pt not_active IP Right Cessation
- 2001-04-17 DK DK01925065T patent/DK1282625T3/da active

Also Published As

Publication number	Publication date
DE60104110T2 (de)	2005-08-25
US6812228B2 (en)	2004-11-02
US20030220335A1 (en)	2003-11-27
ES2223824T3 (es)	2005-03-01
WO2001085734A1 (en)	2001-11-15
MXPA02010270A (es)	2003-04-25
BR0110643A (pt)	2003-03-18
CA2407789A1 (en)	2001-11-15
JP2003532733A (ja)	2003-11-05
DE60104110D1 (de)	2004-08-05
EP1282625B1 (de)	2004-06-30
PT1282625E (pt)	2004-10-29
EP1282625A1 (de)	2003-02-12
AU2001251662A1 (en)	2001-11-20
DK1282625T3 (da)	2004-11-15

Similar Documents

Publication	Publication Date	Title
JO2668B1 (en)	2012-06-17	Isoxazolines For Controlling Invertebrate Pests
DE60220422D1 (de)	2007-07-12	Substituierte pyrazoloverbindungen zur behandlung von entzündungen
SG128491A1 (en)	2007-01-30	Heterocyclic sulfonamide inhibitors of beta amyloid production
MY135841A (en)	2008-07-31	Novel benzodioxoles
GB0318447D0 (en)	2003-09-10	Therapeutic agents
GB9524157D0 (en)	1996-01-24	Therapeutic agents
IL171977A0 (en)	2006-04-10	Cyclic sulfonamides for inhibition of gamma-secretase
SE0104332D0 (sv)	2001-12-19	Therapeutic agents
DK1480961T3 (da)	2007-05-07	Glutaminylbaserede DPIV-inhibitorer
BG108207A (en)	2004-12-30	Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
ATE388146T1 (de)	2008-03-15	1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
BRPI0418181A (pt)	2007-04-27	emprego de 2-aminotetralinas substituìdas para prevenção do tratamento de morbus parkinson
MXPA05007115A (es)	2005-11-16	Nuevos agonistas inversos del receptor cb 1.
UY25143A1 (es)	1998-11-27	Procedimiento para la preparacion de inhibidores de proteasas.
DK0635015T3 (da)	1997-03-17	Acylaminoindolderivater som 5-Htl agonister
DE69713273D1 (de)	2002-07-18	Verwendung von 3,4-Diphenylchromanen zur Herstellung eines Arzneimittels zur Behandlung bzw. Vorbeugung des Prostatakarzinoms
TW200607808A (en)	2006-03-01	Pyrido-pyrimidine derivatives, preparation thereof and application thereof
PE20050254A1 (es)	2005-04-11	N-[3-(3-SUSTITUIDAS-PIRAZOLO [1,5-a]PIRIMIDIN-7-IL) FENIL]-SULFONAMIDAS Y COMPOSICIONES RELACIONADAS
DE69828197D1 (de)	2005-01-20	Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DE60104110D1 (de)	2004-08-05	Benzoxazine zur verwendung in der behandlung parkinsonscher krankheit
ATE397609T1 (de)	2008-06-15	Corticotropinfreisetzungsfaktor antagonisten
ATE273978T1 (de)	2004-09-15	7-aminopyrido(2,3-d)-pyrimidine derivate zur behandlung von bronchialasthma
ES2193047T3 (es)	2003-11-01	(3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas.
ATE250027T1 (de)	2003-10-15	Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DK1049670T3 (da)	2002-11-11	Azetidincarboxamidderivater til behandling af CNS-lidelser

Legal Events

Date

Code

Title

Description

2005-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1282625

Country of ref document: EP

2008-01-15

REN

Ceased due to non-payment of the annual fee